T1	Participants 779 842	Interferon alpha monotherapy relapsers with chronic hepatitis C
T2	Participants 1181 1247	Only patients with negative HCV RNA at week 10 continued treatment
T3	Participants 1308 1453	Thirty-seven patients were enrolled, 19 (6 females, median age 43) in the 24 week and 18 (5 females, median age 40) in the 48 week treatment arm.
